Advanced search
Add to list

Biomonitoring for genotoxic effects has a low sensitivity in terms of cancer risks associated with lifelong exposures starting in utero

(2007) BIOMEDICINE & PHARMACOTHERAPY. 61(10). p.679-681
Author
Organization

Citation

Please use this url to cite or link to this publication:

MLA
Van Larebeke, Nicolas. “Biomonitoring for Genotoxic Effects Has a Low Sensitivity in Terms of Cancer Risks Associated with Lifelong Exposures Starting in Utero.” BIOMEDICINE & PHARMACOTHERAPY 61.10 (2007): 679–681. Print.
APA
Van Larebeke, N. (2007). Biomonitoring for genotoxic effects has a low sensitivity in terms of cancer risks associated with lifelong exposures starting in utero. BIOMEDICINE & PHARMACOTHERAPY, 61(10), 679–681.
Chicago author-date
Van Larebeke, Nicolas. 2007. “Biomonitoring for Genotoxic Effects Has a Low Sensitivity in Terms of Cancer Risks Associated with Lifelong Exposures Starting in Utero.” Biomedicine & Pharmacotherapy 61 (10): 679–681.
Chicago author-date (all authors)
Van Larebeke, Nicolas. 2007. “Biomonitoring for Genotoxic Effects Has a Low Sensitivity in Terms of Cancer Risks Associated with Lifelong Exposures Starting in Utero.” Biomedicine & Pharmacotherapy 61 (10): 679–681.
Vancouver
1.
Van Larebeke N. Biomonitoring for genotoxic effects has a low sensitivity in terms of cancer risks associated with lifelong exposures starting in utero. BIOMEDICINE & PHARMACOTHERAPY. ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER; 2007;61(10):679–81.
IEEE
[1]
N. Van Larebeke, “Biomonitoring for genotoxic effects has a low sensitivity in terms of cancer risks associated with lifelong exposures starting in utero,” BIOMEDICINE & PHARMACOTHERAPY, vol. 61, no. 10, pp. 679–681, 2007.
@article{391407,
  author       = {{Van Larebeke, Nicolas}},
  issn         = {{0753-3322}},
  journal      = {{BIOMEDICINE & PHARMACOTHERAPY}},
  language     = {{eng}},
  number       = {{10}},
  pages        = {{679--681}},
  publisher    = {{ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER}},
  title        = {{Biomonitoring for genotoxic effects has a low sensitivity in terms of cancer risks associated with lifelong exposures starting in utero}},
  volume       = {{61}},
  year         = {{2007}},
}

Web of Science
Times cited: